Skip to main content

Want a detailed portfolio tracker?

Lunai Bioworks (LNAI) P/E (2015 - 2026)

Lunai Bioworks (LNAI) P/E from Feb 2, 2015 to Jun 3, 2026. The TTM Lunai Bioworks (LNAI) P/E is -27.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lunai Bioworks (LNAI)

YearP/EChange
2026-27.80+1123.85%
2025-2.27+115.45%
2024-1.05-85.59%
2023-7.32+1380.31%
2022-0.49-94.97%
2021-9.84-21.72%
2020-12.57-57.48%
2019-29.55+137.93%
2018-12.42-95.97%
2017-308.52+370.34%
2016-65.60-47.60%
2015-125.18N/A

Comparison Lunai Bioworks (LNAI) P/E with competitors

Lunai Bioworks (LNAI) P/E is -27.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.37%
ENLVEnlivex Therapeutics Ltd0.15-100.54%
FGENFibroGen Inc0.24-100.86%
TRAWTraws Pharma Inc0.47-101.70%
FBIOFortress Biotech Inc0.71-102.54%
CHRSCoherus Biosciences Inc0.98-103.52%
ORMPOramed Pharmaceuticals Inc1.47-105.30%
AGENAgenus Inc2.05-107.37%
VIVSVivoSim Labs Inc2.54-109.12%
INVAInnoviva Inc3.19-111.47%
CRMDCorMedix Inc3.65-113.12%
ABEOAbeona Therapeutics Inc4.20-115.13%
VXRTVaxart Inc4.26-115.33%
CVACCureVac N.V.4.45-115.99%
SRPTSarepta Therapeutics Inc4.62-116.64%
GLPGGalapagos NV4.86-117.48%
RIGLRigel Pharmaceuticals4.92-117.70%
ZVRAZevra Therapeutics Inc4.97-117.89%
ABUSArbutus Biopharma Corp5.69-120.48%
CGENCompugen Ltd7.38-126.56%
AUPHAurinia Pharmaceuticals Inc9.25-133.28%
ACADAcadia Pharmaceuticals Inc9.59-134.49%
OMEROmeros Corporation9.88-135.56%
PLXProtalix BioTherapeutics Inc9.91-135.65%
SPROSpero Therapeutics Inc10.73-138.62%
ADMAAdma Biologics Inc11.33-140.76%
SVASinovac Biotech Ltd11.44-141.14%
TBPHTheravance Biopharma Inc11.78-142.37%
HRMYHarmony Biosciences Holdings Inc12.18-143.82%
TGTXTG Therapeutics Inc13.18-147.41%
INCYIncyte Corp13.38-148.14%
SABSSAB Biotherapeutics Inc14.06-150.57%
XOMAXOMA Corp14.95-153.77%
REGNRegeneron Pharmaceuticals Inc14.98-153.89%
PBYIPuma Biotechnology Inc15.05-154.14%
EXELExelixis Inc15.79-156.82%
NAGENiagen Bioscience Inc16.35-158.84%
CPRXCatalyst Pharmaceuticals Inc17.34-162.40%
MDXGMimedx Group Inc17.38-162.51%
ARGXArgen X SE23.07-183.00%
HALOHalozyme Therapeutics Inc23.20-183.46%
XOMAOXOMA Corp25.34-191.18%
VRTXVertex Pharmaceuticals Inc25.66-192.30%
XOMAPXOMA Corp25.67-192.35%
CTMXCytomX Therapeutics Inc25.70-192.45%
ASNDAscendis Pharma A/S26.35-194.81%
RPRXRoyalty Pharma plc - Class A27.50-198.92%
SLNOSoleno Therapeutics Inc29.02-204.38%
LGNDLigand Pharmaceuticals Inc - Class B30.19-208.60%
BMRNBiomarin Pharmaceutical Inc37.51-234.93%
APLSApellis Pharmaceuticals Inc39.02-240.38%
KRYSKrystal Biotech Inc39.70-242.81%
GMABGenmab40.20-244.63%
ONCBeiGene Ltd67.03-341.13%
TECHBio-Techne Corp68.59-346.77%
VCELVericel Corp80.63-390.07%
PHARPharming Group N.V.87.74-415.65%
ALNYAlnylam Pharmaceuticals Inc124.93-549.45%
TLXTelix Pharmaceuticals Ltd139.89-603.26%
CORTCorcept Therapeutics Inc158.39-669.81%